Cargando…

Genotype-Dependent Effects of Dalcetrapib on Cholesterol Efflux and Inflammation: Concordance With Clinical Outcomes

BACKGROUND—: Dalcetrapib effects on cardiovascular outcomes are determined by adenylate cyclase 9 gene polymorphisms. Our aim was to determine whether these clinical end point results are also associated with changes in reverse cholesterol transport and inflammation. METHODS AND RESULTS—: Participan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tardif, Jean-Claude, Rhainds, David, Brodeur, Mathieu, Feroz Zada, Yassamin, Fouodjio, René, Provost, Sylvie, Boulé, Marie, Alem, Sonia, Grégoire, Jean C., L’Allier, Philippe L., Ibrahim, Reda, Guertin, Marie-Claude, Mongrain, Ian, Olsson, Anders G., Schwartz, Gregory G., Rhéaume, Eric, Dubé, Marie-Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982759/ https://www.ncbi.nlm.nih.gov/pubmed/27418594 http://dx.doi.org/10.1161/CIRCGENETICS.116.001405

Ejemplares similares

Dalcetrapib and anacetrapib increase apolipoprotein E-containing HDL in rabbits and humans
por: Brodeur, Mathieu R., et al.
Publicado: (2022)

Dalcetrapib and anacetrapib differently impact HDL structure and function in rabbits and monkeys
por: Brodeur, Mathieu R., et al.
Publicado: (2017)

Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial( )
por: Tardif, Jean Claude, et al.
Publicado: (2022)

Inhibition of the 3CL Protease and SARS-CoV-2 Replication by Dalcetrapib
por: Niesor, Eric J, et al.
Publicado: (2021)

Variants at the APOE/C1/C2/C4 Locus Modulate Cholesterol Efflux Capacity Independently of High‐Density Lipoprotein Cholesterol
por: Low‐Kam, Cécile, et al.
Publicado: (2018)

Impact of regular physical activity on weekly warfarin dose requirement
por: Rouleau-Mailloux, Étienne, et al.
Publicado: (2015)

Pharmacogenomics of the Efficacy and Safety of Colchicine in COLCOT
por: Dubé, Marie-Pierre, et al.
Publicado: (2021)

A genetic association study of heart failure: more evidence for the role of BAG3 in idiopathic dilated cardiomyopathy
por: de Denus, Simon, et al.
Publicado: (2020)

Beneficial Effects of Reconstituted High-Density Lipoprotein (rHDL) on Circulating CD34(+) Cells in Patients after an Acute Coronary Syndrome
por: Gebhard, Catherine, et al.
Publicado: (2017)

Critical Appraisal of C-Reactive Protein Throughout the Spectrum of Cardiovascular Disease
por: Osman, Raed, et al.
Publicado: (2006)

Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease
por: Schwartz, Gregory G., et al.
Publicado: (2020)

Clinical Pharmacokinetics and Pharmacodynamics of Dalcetrapib
por: Black, Donald M., et al.
Publicado: (2018)

Effects of the P‐Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention According to Timing of Infusion: Insights From the SELECT‐ACS Trial
por: Stähli, Barbara E., et al.
Publicado: (2016)

A sex-specific evolutionary interaction between ADCY9 and CETP
por: Gamache, Isabel, et al.
Publicado: (2021)

Nuclear receptor gene polymorphisms and warfarin dose requirements in the Quebec Warfarin Cohort
por: Shahabi, Payman, et al.
Publicado: (2018)

A Pharmacogenetic Investigation of Intravenous Furosemide in Decompensated Heart Failure: A Meta-Analysis of 3 Clinical Trials
por: de Denus, Simon, et al.
Publicado: (2016)

In Vivo Near-Infrared Fluorescence Imaging of Atherosclerosis Using Local Delivery of Novel Targeted Molecular Probes
por: Bertrand, Marie-Jeanne, et al.
Publicado: (2019)

Validating Intravascular Imaging with Serial Optical Coherence Tomography and Confocal Fluorescence Microscopy
por: Tardif, Pier-Luc, et al.
Publicado: (2016)

Predictive risk factors for hospitalization and response to colchicine in patients with COVID-19
por: Tardif, Jean-Claude, et al.
Publicado: (2022)

Cholesteryl ester transfer protein inhibitors for dyslipidemia: focus on dalcetrapib
por: Goldberg, Alyse S, et al.
Publicado: (2012)

Leveraging large observational studies to discover genetic determinants of drug concentrations: A proof‐of‐concept study
por: Meloche, Maxime, et al.
Publicado: (2022)

Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)
por: Bouabdallaoui, Nadia, et al.
Publicado: (2020)

Colchicine reduces atherosclerotic plaque vulnerability in rabbits
por: Roubille, François, et al.
Publicado: (2021)

Colchicine reduces lung injury in experimental acute respiratory distress syndrome
por: Dupuis, Jocelyn, et al.
Publicado: (2020)

Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)
por: Samuel, Michelle, et al.
Publicado: (2020)

Genetics of symptom remission in outpatients with COVID-19
por: Dubé, Marie-Pierre, et al.
Publicado: (2021)

An association study of ABCG2 rs2231142 on the concentrations of allopurinol and its metabolites
por: Pilon, Marc‐Olivier, et al.
Publicado: (2022)

Effect of Perindopril on Atrial Fibrillation Recurrence and Burden: Results of the Canadian Trial of Atrial Fibrillation (CTAF)-2
por: Rivard, Lena, et al.
Publicado: (2021)

Impact of amiodarone use on metoprolol concentrations, α‐OH‐metoprolol concentrations, metoprolol dosing and heart rate: A cross‐sectional study
por: Robert, Sabrina, et al.
Publicado: (2023)

Females present higher dose‐adjusted drug concentrations of metoprolol and allopurinol/oxypurinol than males
por: Hindi, Jessica, et al.
Publicado: (2023)

Safety and tolerability of dalcetrapib (RO4607381/JTT-705): results from a 48-week trial
por: Stein, Evan A., et al.
Publicado: (2010)

Erratum to: Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial
Publicado: (2022)

CYP3A4 genotype is associated with sildenafil concentrations in patients with heart failure with preserved ejection fraction
por: de Denus, Simon, et al.
Publicado: (2017)

Comparison of genotype clustering tools with rare variants
por: Perreault, Louis-Philippe Lemieux, et al.
Publicado: (2014)

Circulating levels of linoleic acid and HDL-cholesterol are major determinants of 4-hydroxynonenal protein adducts in patients with heart failure()
por: Asselin, Caroline, et al.
Publicado: (2013)

Fourteen-Day Evolution of COVID-19 Symptoms during the Third Wave in Nonvaccinated Subjects and Effects of Hesperidin Therapy: A Randomized, Double-Blinded, Placebo-Controlled Study
por: Dupuis, Jocelyn, et al.
Publicado: (2022)

Pillbox Use and INR Stability in a Prospective Cohort of New Warfarin Users
por: Dumas, Stephanie, et al.
Publicado: (2016)

Dalcetrapib: JTT 705; JTT-705; R 1658; R1658; RG1658; RO 4607381; RO4607381
Publicado: (2012)

Factors Associated With Burnout, Post-traumatic Stress and Anxio-Depressive Symptoms in Healthcare Workers 3 Months Into the COVID-19 Pandemic: An Observational Study
por: Cyr, Samuel, et al.
Publicado: (2021)

Hair cortisol change at COVID-19 pandemic onset predicts burnout among health personnel
por: Marcil, Marie-Joëlle, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m10bgch2t2akfcu7blvcno5uo2